HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 27/2/178    most recent 00060.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (25) Citing Articles via Google Scholar Google Scholar Articles by Atherton, H. J. Articles by Griffin, J. L. Search for Related Content PubMed PubMed Citation Articles by Atherton, H. J. Articles by Griffin, J. L.

A combined ¹H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR- null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome

¹ Department of Biochemistry, University of Cambridge, Cambridge
² Selcia Limited, Ongar, Essex
³ University Laboratory of Physiology, University of Oxford, Oxford
⁴ Waters Corporation, Manchester, United Kingdom

The mobilization of triacylglycerides from storage in adipocytes to the liver is a vital response to the fasting state in mammalian metabolism. This is accompanied by a rapid translational activation of genes encoding mitochondrial, microsomal, and peroxisomal ß-oxidation in the liver, in part under the regulation of peroxisome proliferator-activated receptor- (PPAR-). A failure to express PPAR- results in profound metabolic perturbations in muscle tissue as well as the liver. These changes represent a number of deficits that accompany diabetes, dyslipidemia, and the metabolic syndrome. In this study, the metabolic role of PPAR- has been investigated in heart, skeletal muscle, liver, and adipose tissue of PPAR- null mice at 1 mo of age using metabolomics. To maximize the coverage of the metabolome in these tissues, ¹H-NMR spectroscopy, magic angle spinning ¹H-NMR spectroscopy, gas chromatography-mass spectrometry, and liquid chromatography-mass spectrometry were used to examine metabolites in aqueous tissue extracts and intact tissue. The data were analyzed by the multivariate approaches of principal components analysis and partial least squares. Across all tissues, there was a profound decrease in glucose and a number of amino acids, including glutamine and alanine, and an increase in lactate, demonstrating that a failure to express PPAR- results in perturbations in glycolysis, the citric acid cycle, and gluconeogenesis. Furthermore, despite PPAR- being weakly expressed in adipose tissue, a profound metabolic perturbation was detected in this tissue.

metabolic profiling; metabonomics; gluconeogenesis; lipid metabolism; metabolic regulation; peroxisome proliferator-activated receptor-

This article has been cited by other articles:

				J. R. Bain, R. D. Stevens, B. R. Wenner, O. Ilkayeva, D. M. Muoio, and C. B. Newgard Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge Diabetes, November 1, 2009; 58(11): 2429 - 2443. [Full Text] [PDF]

				M. A. Schroeder, H. J. Atherton, D. R. Ball, M. A. Cole, L. C. Heather, J. L. Griffin, K. Clarke, G. K. Radda, and D. J. Tyler Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy FASEB J, August 1, 2009; 23(8): 2529 - 2538. [Abstract] [Full Text] [PDF]

				M. Sieber, D. Hoffmann, M. Adler, V. S. Vaidya, M. Clement, J. V. Bonventre, N. Zidek, E. Rached, A. Amberg, J. J. Callanan, et al. Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity Toxicol. Sci., June 1, 2009; 109(2): 336 - 349. [Abstract] [Full Text] [PDF]

				L. Makowski, R. C. Noland, T. R. Koves, W. Xing, O. R. Ilkayeva, M. J. Muehlbauer, R. D. Stevens, and D. M. Muoio Metabolic profiling of PPAR{alpha}-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation FASEB J, February 1, 2009; 23(2): 586 - 604. [Abstract] [Full Text] [PDF]

				M. Mayr Metabolomics: Ready for the Prime Time? Circ Cardiovasc Genet, October 1, 2008; 1(1): 58 - 65. [Full Text] [PDF]

				J. L. Griffin and A. Vidal-Puig Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics, June 1, 2008; 34(1): 1 - 5. [Abstract] [Full Text] [PDF]

				R. Gelinas, F. Labarthe, B. Bouchard, J. Mc Duff, G. Charron, M. E. Young, and C. Des Rosiers Alterations in carbohydrate metabolism and its regulation in PPAR{alpha} null mouse hearts Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1571 - H1580. [Abstract] [Full Text] [PDF]

				I. Lekli, G. Szabo, B. Juhasz, S. Das, M. Das, E. Varga, L. Szendrei, R. Gesztelyi, J. Varadi, I. Bak, et al. Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H859 - H866. [Abstract] [Full Text] [PDF]